CELLINK, a leading global 3D bioprinting company, is collaborating with the Indian Institute of Science (IISc) Bengaluru, to establish a Center of Excellence (CoE) to advance 3D bioprinting research in India on the heart, bone, cartilage, and cancer. The Centre for Excellence (CoE), the first of its kind on the Indian subcontinent, would be housed at IISc's Centre for BioSystems Science and Engineering in Bengaluru (BSSE).
According to a statement issued by IISc on Friday, the center will provide researchers with access to 3D bioprinting technology, allowing them to move more quickly on critical applications with the ultimate goal of improving health outcomes.
On August 18, an agreement was signed to formalize the partnership. The use of additive manufacturing processes on living cells, growth factors, and/or biomaterials to create biomedical parts, frequently with the goal of mimicking the properties of natural tissue, is known as 3D bioprinting. 3D bioprinting covers a wide range of bioprinting methods and substances. Tissue and organ models can now be printed using bioprinting to aid in drug and therapy research.
3D Bioprinting Research in India
“The Center will focus on work related to the heart, bone, cartilage, and cancer. We are thrilled to host this CoE in the Institute, which will aid in the launch of cutting-edge research in an emerging field of technology with enormous potential to benefit human health.”
- Narendra Dixit, Chairperson professor, BSSE
It was announced that IISc and CELLINK will collaborate to hold seminars to teach researchers at the institute and around the world how to use 3D bioprinting and benefit from 3D cell culture. In addition, the two will collaborate on 3D bioprinting research projects for a variety of applications including tissue engineering, drug discovery, material science, and regenerative/individualized medicine.
